440 related articles for article (PubMed ID: 1855750)
1. [Conservative therapy of ulcerative colitis and Crohn disease].
Rasenack J; Kreisel W
Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
[TBL] [Abstract][Full Text] [Related]
2. [Local or systemic treatment of inflammatory bowel diseases?].
Schmassmann A; Halter F
Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
[TBL] [Abstract][Full Text] [Related]
3. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
4. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
5. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
Maier K; Fischer C; Klotz U; Heinkel K
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
Schölmerich J; Gerok W
Wien Klin Wochenschr; 1986 Nov; 98(22):762-9. PubMed ID: 2880425
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy for ulcerative colitis in childhood.
Ament ME; Vargas JH
Semin Pediatr Surg; 1994 Feb; 3(1):28-32. PubMed ID: 7914811
[TBL] [Abstract][Full Text] [Related]
8. Topical salicylate therapy (4-ASA and 5-ASA enemas).
Ginsberg AL
Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
[TBL] [Abstract][Full Text] [Related]
9. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Schölmerich J
Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
[TBL] [Abstract][Full Text] [Related]
10. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Sutherland LR
CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
[TBL] [Abstract][Full Text] [Related]
11. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
Fahrländer H
Schweiz Med Wochenschr; 1987 Oct; 117(42):1620-3. PubMed ID: 3321418
[TBL] [Abstract][Full Text] [Related]
12. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
Marshall JK; Irvine EJ
Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
[TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
Fischbach W
Leber Magen Darm; 1992 Mar; 22(2):49-55. PubMed ID: 1350043
[TBL] [Abstract][Full Text] [Related]
14. [Acute manifestations in Crohn disease and ulcerative colitis. Conservative treatment of acute situations].
Goebell H
Langenbecks Arch Chir; 1988; Suppl 2():77-81. PubMed ID: 2907077
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic therapy for inflammatory bowel disease.
Hirschfeld S; Clearfield HR
Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
[TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of ulcerative colitis].
Rückert Y
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
[TBL] [Abstract][Full Text] [Related]
17. A practical guide to the management of distal ulcerative colitis.
Ardizzone S; Bianchi Porro G
Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
[TBL] [Abstract][Full Text] [Related]
18. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease.
Robinson MG
Gastroenterol Clin North Am; 1989 Mar; 18(1):43-50. PubMed ID: 2646221
[TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine and 5-ASA compounds.
Allgayer H
Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
[TBL] [Abstract][Full Text] [Related]
20. Are patients with inflammatory bowel disease receiving optimal care?
Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]